Continuous glucose monitors (CGMs) — medical devices originally developed for type 1 and type 2 diabetes management — have crossed into the consumer wellness market, with companies like Levels, Nutrisense, and January AI offering CGM subscriptions to non-diabetic individuals seeking metabolic insight. The pitch: real-time glucose data reveals which foods spike blood sugar, how exercise affects glucose, and enables personalized "metabolic optimization." The question: does CGM provide actionable, evidence-based value for people without diabetes, or is it a sophisticated biofeedback tool solving a problem most people don't have?
What CGM Measures and Its Limitations
CGMs measure interstitial fluid glucose (not blood glucose directly) with 10–15 minute lag versus capillary blood glucose — clinically acceptable for diabetes management (where glucose stays elevated for hours) but potentially misleading for the rapid postprandial spikes seen in non-diabetics. Normal postprandial glucose response: non-diabetics routinely exceed "spike" thresholds (>140 mg/dL) after mixed meals — this is physiologically normal pancreatic response, not pathological. In healthy individuals, continuous glucose rarely stays elevated: the pancreas secretes insulin precisely and rapidly, returning glucose to baseline within 1–2 hours of meals. The "glucose spike" framing from wellness CGM companies pathologizes normal physiology — a person with excellent metabolic health will still show CGM spikes after eating rice or fruit.
Is There Evidence CGM Improves Outcomes in Non-Diabetics?
Direct evidence is sparse. The strongest arguments: CGM may improve behavior by providing real-time feedback that motivates dietary changes (mechanistic plausibility); CGM may identify individuals with prediabetes who were unaware (legitimate screening value — though a fasting glucose or HbA1c is cheaper and more validated for this purpose). Counter-evidence: a 2023 JAMA Internal Medicine analysis found CGM-guided recommendations from wellness companies frequently contradicted food choices that evidence-based nutrition research supports (e.g., flagging bananas as "spiking" while evidence shows fruit consumption reduces T2DM risk). CGM-induced food anxiety and restrictive eating patterns are documented adverse effects in the wellness CGM literature. For clinical glucose monitoring in medical settings, our diagnostic equipment catalog includes clinical-grade glucose meters and monitoring supplies for appropriate diagnostic use.
